Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 451-475 of 1,000 matching filings.

Per page
25
Current page
19
SC 13G File 005-48459

SCHEDULE 13G

Filing date
15 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
14 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
09 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
09 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
07 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-200452

424B2

Filing date
07 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-200452

FWP

Filing date
06 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200452

424B5

Filing date
05 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
05 Jun 2017
Reporting date
02 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
26 May 2017
Reporting date
26 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-28386

CT ORDER filing

Filing date
22 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
16 May 2017
Reporting date
16 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-12465

CT ORDER filing

Filing date
08 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-12465

CT ORDER filing

Filing date
08 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 May 2017
Reporting date
29 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 May 2017
Reporting date
29 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 May 2017
Reporting date
29 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 May 2017
Reporting date
29 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
27 Apr 2017
Reporting date
27 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .